• 1
    Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Balt) 1992; 71:20615.
  • 2
    Späth PJ. C1 inhibitor. In: Haeberli A, ed. Human protein data. Weinheim: Wiley-VCH Verlag Gmbh, 1997.
  • 3
    Quastel M, Harrison R, Cicardi M, Alper CA, Rosen FS. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 1983; 71:10416.
  • 4
    Cugno M, Nuijens J, Hack E et al. Plasma levels of C1-inhibitor complexes and cleaved C1-inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 1990; 85:121520.
  • 5
    Schreiber AD, Kaplan AP, Austen KF. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest 1973; 52:14029.
  • 6
    de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Invest 1984; 73:15429.
  • 7
    Cugno M, Bos I, Lubbers Y, Hack CE, Agostoni A. In vitro interaction of C1-inhibitor with thrombin. Blood Coagul Fibrinolysis 2001; 12:25360.
  • 8
    Van Nostrand WE, McKay LD, Baker JB, Cunningham DD. Functional and structural similarities between protease nexin I and C1 inhibitor. J Biol Chem 1988; 263:397983.
  • 9
    Harpel PC, Cooper NR. Studies on human plasma C1 inactivator–enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin. J Clin Invest 1975; 55:593604.
  • 10
    Cugno M, Cicardi M, Bottasso B et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 1997; 89:32138.
  • 11
    Nielsen EW, Morrissey J, Olsen JO, Osterud B. Factor VIIa in patients with C1-inhibitor deficiency. Thromb Haemost 1995; 74:11036.
  • 12
    Joseph K, Tholanikunnel TE, Kaplan AP. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis. Ann Allergy Asthma Immunol 2010; 104:504.
  • 13
    Garcia JG, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW, Malik AB. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 1986; 128:96104.
  • 14
    DeMichele MA, Moon DG, Fenton JW, Minnear FL. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol 1990; 69:1599606.
  • 15
    Garcia JG, Pavalko FM, Patterson CE. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibrinolysis 1995; 6:60926.
  • 16
    Frank MM, Sergent JS, Kane MA, Alling DW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med 1972; 286:80812.
  • 17
    Levi M, Hack CE, de Boer JP, Brandjes DP, Buller HR, ten Cate JW. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. J Clin Invest 1991; 88:115560.
  • 18
    Kluft C, Dooijewaard G, Emeis JJ. Role of the contact system in fibrinolysis. Semin Thromb Hemost 1987; 13:5068.
  • 19
    Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986; 261:34869.
  • 20
    Cugno M, Hack CE, de Boer JP, Eerenberg AJ, Agostoni A, Cicardi M. Generation of plasmin during acute attacks of hereditary angioedema. J Lab Clin Med 1993; 121:3843.
  • 21
    Kleniewski J, Blankenship DT, Cardin AD, Donaldson V. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. J Lab Clin Med 1992; 120:12939.
  • 22
    Kaplan AP, Austen KF. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med 1971; 133:696712.
  • 23
    van Geffen M, Loof A, Lap P et al. A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis. Hematology 2011; 16:32736.
  • 24
    Radcliffe R, Bagdasarian A, Colman R, Nemerson Y. Activation of bovine factor VII by hageman factor fragments. Blood 1977; 50:6117.
  • 25
    Cugno M, Bergamaschini L, Uziel L et al. Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency). J Clin Chem Clin Biochem 1988; 26:4237.
  • 26
    Aerzteschaft AdD. Schwerwiegende Thrombenbildung nach Berinert HS [Serious thrombosis after Berinert HS]. Dtsch Aerztebl 2000; 97:B864.
  • 27
    Cugno M, Cicardi M, Agostoni A. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol 1994; 93:8706.